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Abstract Low back pain is the most common pain
symptom experienced by American adults and is the second
most common reason for primary care physician visits.
There are many structures in the lumbar spine that can serve
as pain generators and often the etiology of low back pain is
multifactorial. However, the facet joint has been increas-
ingly recognized as an important cause of low back pain.
Facet joint pain can be diagnosed with local anesthetic
blocks of the medial branches or of the facet joints them-
selves. Subsequent radiofrequency lesioning of the medial
branches can provide more long-term pain relief. Despite
some of the pitfalls associated with facet joint blocks, they
have been shown to be valid, safe, and reliable as a diag-
nostic tool. Medial branch denervation has shown some
promise for the sustained control of lumbar facet joint-
mediated pain, but at this time, there is insufﬁcient evidence
that it is a whollyefﬁcacious treatment option. Developing a
universal algorithm for evaluating facet joint-mediated pain
and standard procedural techniques may facilitate the per-
formance of larger outcome studies. This review article
provides an overview of the anatomy, pathophysiology,
diagnosis, and treatment of facet joint-mediated pain.
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Introduction
Low back pain is the most common pain symptom expe-
rienced by American adults and is the second most
common reason for primary care physician visits [1]. One
study reported that over one-quarter of the U.S. population
had experienced an episode of low back pain in the three
months prior to the survey [2]. Although the majority of
episodes last less then 3 months, many patients experience
recurrent attacks [3]. Those patients who go on to develop
chronic low back pain (lasting greater than 3 months)
account for an estimated $100–$200 billion dollars of
healthcare spending per year [4]. Despite our enhanced
understanding of pain neural pathways and improvements
in imaging technology, diagnosing the exact etiology of
low back pain and treating it continues to be a challenge.
There are many structures in the lumbar spine that can
serve as pain generators and often, the etiology of low back
pain is multifactorial. Since being described as a potential
pain generator by Joel Goldthwait in 1911 [5], the facet
joint has been increasingly recognized as an important
cause of low back pain. The use of the term facet syndrome
was ﬁrst coined by Ghormely in 1933 [6]. A facet joint
(also referred to as a zygapophysial joint) is located at the
junction of the inferior articular process of a more cephalad
vertebra and the superior articular process of a more caudal
vertebra. It has been estimated that facet joint pathology is
a contributory factor in 15–52% of patients with chronic
low back pain [7–13]. However, it has also been reported
that the prevalence of isolated facet joint pain may be as
low as 4% [14].
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debatable, the presence of facet joint arthrosis in different
age groups is clear. Eubanks et al. examined prevalence
rates of facet arthrosis on 647 cadaveric lumbar spines.
Fifty-seven percent of samples between 20 and 29 years of
age and 93% of the samples between 40 and 49 years of
age had evidence of facet arthrosis. By the age of 60, 100%
of the samples had prominent facet arthrosis. The highest
prevalence and the greatest severity of arthrosis were found
at L4–L5 [15].
Facet joint pain can be diagnosed and treated with facet
jointinjectionsandeventually,withradiofrequencylesioning
of the medial branches. These are some of the most common
interventional pain procedures performed with over 175,000
Medicare billings recorded in 2001 [16].
This review article will provide an overview of the
anatomy, pathophysiology, diagnosis, and treatment of
facet joint-mediated pain.
Anatomy
Previous studies have demonstrated that both the capsule
[17, 18], and synovial folds [19, 20] of facet joints possess
nociceptive nerve endings. Pain sensation from the capsule
and synovium are transmitted through the medial branches
of the dorsal ramus of spinal nerves. In addition, the medial
branches also supply the multiﬁdus muscle, ligaments, and
the periosteum of the vertebral arches and spines [21, 22].
The facet joint in the lumbar spine is innervated by the
medial branch of the dorsal ramus of the nerve exiting at
the same level and also the medial branch of the nerve one
level above. For example, when considering the L4–L5
facet joint, innervation is supplied by the medial branches
originating from the L3 and L4 nerves. In this example, the
medial branch from the L3 nerve supplies the inferior
articular process of the L4 vertebrae. This is equivalent to
the superior articulation of the facet joint. Likewise, the
medial branch of the L4 nerve supplies the superior artic-
ular process of the L5 vertebrae, which also represents the
inferior articulation of the L4–L5 facet joint.
As each medial branch passes inferiorly, it lies in a
groove along the medial–posterior surface of the transverse
process [23–26]. The medial branch courses over the
transverse processes one level inferior to where it origi-
nates. This is related to the fact that there is a C8 nerve but
no C8 vertebrae. For example, the C6–C7 facet joint is
innervated by the medial branches of C6 and C7. However,
the C7–T1 facet joint is innervated by the medial branches
of C7 and C8. The facet joints of T1–T2 are innervated by
the medial branches of C8 and T1. This pattern continues
in the lumbar spine. Of note, the anatomy of the L5–S1
facet joint differs from its lumbar counterparts. It is
innervated by the medial branch of L4 and the dorsal ramus
of L5. The L5 dorsal ramus courses along a groove formed
between the base of the S1 superior articulating process
and the sacral ala [23, 26] (Fig. 1).
The articulating surface of the facet joints is covered by
a layer of hyaline cartilage. Surrounding each facet joint is
a thin ﬁbrous capsule lined with synovial membrane. The
joint capsule plays an important role in the degree of
motion obtainable secondary to the ability of the capsule to
resist ﬂexion moments [27]. In comparison to cervical facet
joint capsules, the lumbar capsules are shorter and more
taught, resulting in a lesser degree of ﬂexion obtained in
the lumbar spine in comparison to the cervical spine.
Experiments in which the joint capsules in the lumbar spine
were excised resulted in increased lumbar range of motion
in the sagittal plane [28].
The orientation of lumbar facet joints has important
functional and clinical consequences. For example, facet
joints oriented relatively more parallel to the sagittal plane,
such as at L2–L3 and L3–L4, allow limited rotational
movements and anatomically favor ﬂexion and extension
movements. In contrast, the L4–L5 facet joints, with
increased coronal angulations, facilitate greater rotational
movements [29–31].
Both facet joint orientation and facet joint tropism (an
asymmetry in the angles of two facet joints at the same
level) have been implicated as important variables leading
to facet joint-mediated pain. Masharawi et al. examined
facet joint morphology in 240 human cadavers. They noted
facet joint tropism was much more common in the thoracic
spine as compared to the lumbar spine [32]. This suggested
that asymmetry of facet joints in the lumbar spine may be
Fig. 1 Anatomic features in the lumbar spine. Adapted from
illustration by Stephen Ponchak MD in Walsh NE. Nociceptive Pain.
In Raj PP, editor: Pain Medicine a Comprehensive Review, second
ed. Elsevier Science, 2003. With permission
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examined 104 cadaveric facet joints for severity of carti-
lage degeneration and found no association with facet
tropism. They reported that the factors associated with
sclerosis and cartilage degeneration of the facet joint were
not facet tropism, but rather advanced age, spinal level, and
increasingly coronal joint angles. However, other studies
have linked degenerative spondylolisthesis to facet joints
that have an increased sagittal orientation [34, 35].
Facet joints may also serve important proprioceptive
functions. This is based on the presence of low threshold,
mechanoreceptors lining the facet capsule. These receptors
are similar to mechanosensitive neurons involved in pro-
prioception of other peripheral joints [36, 37].
Radiographically, the facet joint may be visualized more
clearly with oblique views. With this radiographic angle,
the classic ‘‘Scotty dog’’ is visualized, allowing for easier
recognition of anatomic landmarks. To review, the nose is
formed by the transverse process; the eye formed by the
pedicle, the neck is the pars interarticularis, the ear is
formed by the superior articular process and the front leg
formed by the inferior articular process (Fig. 2).
The facet joint as a pain mediator
In 1963, Hirsch et al. [38] injected 11% hypertonic saline
in the region of the facet joints and provoked low back and
thigh pain. Subsequently, facet joint-mediated pain was
conﬁrmed with more speciﬁc studies involving direct intra-
articular injections of hypertonic saline [39, 40]. In the
study conducted by Mooney and colleagues, the intra-
articular injection of saline was followed by the injection of
local anesthetic. This obliterated the discomfort in all
subjects tested [39]. Similar results were obtained with
subsequent experiments that utilized intra-articular injec-
tion of contrast to provoke pain through distention of the
facet joint capsule [41]. The results of these earlier studies
have been reproduced through experiments involving
stimulation of not only facet joints but also the medial
branches [42].
The development of facet joint-mediated pain involves
both biomechanical and inﬂammatory components. Multi-
ple factors can destabilize the facet joint and its capsule.
Biomechanical model
Intervertebral disc degeneration has been reported to be a
source of low back pain in adults [43]. Studies have linked
pathological changes in facet joints with preceding disc
degeneration [44–46]. The intervertebral discs support
most of the weight during ﬂexed postures but the facet
joints bear an increasingly greater burden as the lumbar
spine is ranged into extension. In addition to stabilizing the
spine and guiding segmental motion, facet joints function
as weight-bearing structures that support axial loading
along with the intervertebral discs. Studies have shown that
the facet joints can carry up to 33% of the dynamic axial
load [47–49]. Disc degeneration with associated narrowing
of the disc space alters the mechanical load distribution and
may result in a degenerative cascade with increased
mechanical stress on the facet joint and joint capsule.
Within the active range of the lumbar spine, the paraspinal
muscles act as the principal contributors to vertebral sta-
bility. However, both cyclic and sustained ﬂexion
movements decrease the reﬂexive muscle activity of the
paraspinal muscles such as the multiﬁdus muscle [50–57].
In theory, this may result in increased laxity across the
facet joint leading to both decreased stability and increased
stress on the facet joint capsule [55].
The role of the facet joint capsule in stabilizing the
motion characteristics of these joints cannot be understated.
Studies have suggested that disc degeneration results in
Fig. 2 Oblique view of the
lumbar spine. SAP superior
articular process, IAP inferior
articular process, P pedicle
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postulated that the increase in axial rotation and subsequent
instability place additional stressors upon the facet joint
capsules leading to a molecular response, which results in
ﬁbrocartilaginous metaplasia in the capsules of facet joints.
Boszczyk et al. [62] reported hypertrophic and ﬁbrocarti-
laginous changes in the facet joint capsules of patients who
had undergone lumbar fusion for degenerative instability.
Chemical model
Changes in load distributions can lead to osteoarthrosis,
osteophyte formation, and inﬂammation [43]. The cartilage
and synovium of facet joints are sources of inﬂammatory
cytokines [63]. It has been proposed that painful symptoms
may arise not only from mechanical stress discussed pre-
viously, but also from the associated inﬂammatory
response involving cytokines such as tumor necrosis factor
alpha, interleukin-6, interleukin 1 beta [63, 64], oxygen-
free radicals such as nitric oxide [65, 66], and inﬂammatory
mediators such as prostaglandins [63, 64, 66]. Interestingly,
some have suggested that inﬂammatory cytokines origi-
nating from inﬂamed synovium may spread to adjacent
nerve roots and produce radicular lower extremity symp-
toms [63, 67–70].
As with other diarthrodial joints, the cartilage of facet
joints may also be sex-hormone sensitive [71]. Estrogen
has been associated with chondrodestruction [72], although
controversy exists as to its actual role in the development
of osteoarthritis [73–76]. However, Ha et al. [77] have
found a statistically signiﬁcant association between the
increased expression of estrogen receptors on the articular
cartilage of facet joints and the severity of facet arthritis.
Diagnosis
When evaluating a patient with low back pain, the initial
differential diagnosis can be broad. While certain symp-
toms in a patient’s history may suggest systemic disease,
neoplasm, or acute nerve compression, the history cannot
always differentiate the speciﬁc etiology of low back pain.
Up to 85% of patients with low back pain do not obtain a
speciﬁc diagnosis even after work up [78–80]. The diag-
nosis of facet joint-mediated pain is no exception. The
history, physical examination and imaging studies cannot
consistently identify facet joint pain [14, 81–86].
A prospective statistical study by Jackson et al. [85],
which included 390 patients and examined 127 variables,
was not able to identify clinical facet joint syndromes or
ﬁnd predictors of who may respond better to facet joint
injections. Furthermore, although pain referral patterns
have been identiﬁed, investigators have been unable to
correlate speciﬁc patterns with individual levels [87, 88].
Mooney and Robertson [39] injected hypertonic saline into
the facet joints of both symptomatic and asymptomatic
patients and noted pain referral patterns that were indis-
tinguishable from pain patterns associated with other
etiologies (Fig. 3).
While changes in facet joint architecture can be detected
with imaging studies, correlation between radiologic ﬁnd-
ings and symptoms has also proven unreliable [82].
Although Laslett and colleagues reported clinical guide-
lines that may be helpful in predicting patient response to
facet joint blocks, the study results have not been replicated
thus far. At this time, accurately diagnosing facet joint-
mediated pain by noninvasive techniques remains a chal-
lenge [89].
Currently, the principal method of diagnosing facet
joint-mediated pain as the cause of low back pain is
through the use of controlled local anesthetic blocks of
either the medial branches or the facet joint itself. Both of
these techniques have been shown to be equally efﬁcacious
[10, 82, 88, 90–92]. These procedures employ the use of
local anesthetics with varying durations of action. For
example, a short acting local anesthetic such as lidocaine is
injected in either the intra-articular facet joint or upon the
medial branches. The patient is observed for pain relief that
is consistent with the duration of action of the local anes-
thetic. Days to weeks after the initial diagnostic block, a
second block is then employed with a local anesthetic that
has a different duration of action such as bupivacaine.
Fig. 3 Pain referral patterns for asymptomatic (normal) and symp-
tomatic (abnormal) patients. From Mooney V. Robertson J. The facet
syndrome. Clinical Orthopaedics & Related Research. (115):149–56,
1976 Mar–Apr. Reprinted with permission
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appropriate to the biological properties of the anesthetic.
This second injection is referred to as the conﬁrmatory
injection. The value of adding a conﬁrmatory block was
demonstrated by Schwarzer et al. [7], who by using the
protocol outlined above, noted a false positive rate of 38%
when a single block was used for the diagnosis of facet
joint-mediated pain.
Although the value of a conﬁrmatory block is recog-
nized, the deﬁnition of a successful block is controversial.
In the above study by Schwarzer et al. [7], a 50% or greater
reduction of pain was accepted as a positive block. A 50%
or greater improvement in pain as criteria for a successful
diagnostic medial branch block has also been used by other
investigators [93–98]. Studies that employed diagnostic
intra-articular blocks as apposed to medial branch blocks
have also used similar criteria of 50% or greater
improvement of pain [99, 100, 107]. However, others have
suggested that a more strict deﬁnition of a conﬁrmatory
block is necessary to avoid performing radiofrequency
denervation on patients who may have low back pain of
other etiologies. When more strict criteria are used, the
speciﬁcity of a diagnostic block may improve.
Other investigators have employed more stringent cri-
teria as the marker for a positive diagnostic medial branch
block. For example, in a 10-year clinical audit examining
the efﬁcacy of radiofrequency denervation, Gofeld and
colleagues [101] accepted a positive response to diagnostic
medial branch blocks only if the patient experienced at
least a 70% reduction in pain scores. In a study assessing
the efﬁcacy of facet joint anesthesia, Revel et al. [102]
considered a positive result only if there was a 75% or
more relief of pain. More recently, Dreyfuss and colleagues
[106] excluded patients from subsequent radiofrequency
denervation if they did not experience at least 80%
improvement in pain scores. In a randomized double blind
trial examining cervical facet joint-mediated pain by Lord
et al. [108], patients were required to experience complete
100% pain relief to be considered as having had a suc-
cessful diagnostic block.
In a review of the evidence based procedural guidelines
that included three randomized controlled trials and two
systematic reviews, Hooten et al. [103] proposed the use of
80% or more relief of pain as the standard for accepting a
diagnostic medial branch block as successful. This criteria,
however, was challenged by a multi-center retrospective
clinical data analysis of 262 patients with chronic low back
pain who had undergone lumbar radiofrequency denerva-
tion. The study group was divided into two groups of
patients. The ﬁrst group included patients who had experi-
enced greater than or equal to 50% but less than 80% pain
relief after diagnostic medial branch blocks. The other
group represented patients that obtained equal to or
greater than 80% pain relief. There was no signiﬁcant dif-
ference between success rates of subsequent radiofrequency
lesioning in these two groups [104].
By utilizing more strict criteria for diagnosing facet joint
pain, we limit the number of false positive results. How-
ever, as the authors of the above study suggest, the use of
more strict criteria may be counterproductive and may lead
to the withholding of a potentially therapeutic treatment
from patients with treatable facet joint-mediated pain.
As we have illustrated, there is a lack of consensus
regarding the deﬁnition of a successful diagnostic block.
Similarly, there is no universally accepted method of
how best to perform these procedures. Although intra-
articular facet joint injections are generally considered to be
more technically challenging, both medial branch blocks
and facet joint injections have their share of technical
complications. Furthermore, even the use of local anesthe-
sia with both of these procedures has been called into
question. Some physicians will administer a local anesthetic
to the muscle and fascia in addition to subcutaneous local
anesthesia. This technique is simply an attempt to improve
patient comfort by anesthetizing the tissue through which
the needle will track. A larger number of false-positive
results have been reported with this technique [10,105]. It is
for this reason that some support the use of local anesthetic
only superﬁcially or of omitting the use of local anesthetic
altogether. It is also important to recognize that in addition
to the potential confounders outlined in this review, these
methods are only as reliable as the ability of the patient to
accurately report their symptoms.
With respect to medial branch blocks, most centers
utilize a multiple needle approach whereby separate nee-
dles are used for each medial branch that is anesthetized.
More recently, however, a new technique involving a sin-
gle needle has been proposed [109]. Although further
studies are needed, initial analysis of this single needle
technique suggests similar accuracy to that of the multiple
needle approach in ability to anesthetize the medial branch
with the advantages of increased efﬁciency and less patient
discomfort [110]. It has also been recognized that when
performing medial branch blocks, subtle differences in
needle position can have important diagnostic conse-
quences. In a cadaveric study, Dreyfuss et al. [111]
reported evidence of local anesthetic spread to other
structures such as the intervertebral foramina as well as
consistent spread to the posterior muscles of the back.
Local anesthetic spread to other potential pain generators
may decrease the diagnostic utility of these injections. Of
note, in this study, when the needle tip was positioned at a
point along the inferior aspect of the transverse process,
aberrant ﬂow was minimized. This suggests that when
appropriate technique is utilized, spread of anesthetic can
be avoided and diagnostic utility may be enhanced.
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Although numerous studies have examined conservative
management for low back pain, at the present time, there
are no published investigations of conservative manage-
ment speciﬁcally targeted to facet joint pain. However,
most experts would agree that the general principles for
treatment of nonspeciﬁc benign low back pain may be
applied. A thorough history and physical exam is always
recommended for diagnostic triage. Initial imaging is not
necessary unless a speciﬁc etiology is strongly suspected or
in the presence of ‘‘red ﬂag’’ signs [112]. The use of a
multidisciplinary approach is recommended for pain man-
agement as it has been associated with improved outcomes
[113]. In terms of medications, simple analgesics such as
acetaminophen and nonsteroidal anti-inﬂammatory drugs
(NSAIDs) constitute ﬁrst-line therapy. Acetaminophen has
a more favorable side-effect proﬁle since it has not been
associated with cardiovascular or gastrointestinal side-
effects. However, with chronic use, hepatic injury is a
concern. Studies in patients with osteoarthritis of the knee
and hip have previously found that NSAID’s provide better
analgesia in comparison to acetaminophen [114, 115]. Both
benzodiazepine and non-benzodiazepine skeletal muscle
relaxants may also provide symptomatic improvement in
acute low back pain. However, there is signiﬁcant contro-
versy regarding the use of controlled substances in the
treatment of chronic low back pain [116]. Anticonvulsants
such as gabapentin have classically been used for the
treatment of neuropathic pain conditions such as diabetic
peripheral neuropathy and postherpetic neuralgia [117,
118]. Gabapentin has been evaluated in trials evaluating
chronic lumbar radiculopathy [119, 120], and lumbar
spinal stenosis [121]. However, these studies were small
and had several shortcomings. Studies examining use of
gabapentin for facet joint-mediated pain have not been
performed. The use of antidepressants, speciﬁcally tricyclic
antidepressants have shown moderate symptom reduction
in patients with chronic low back pain [122, 123]. Again, as
with anticonvulsants, trials examining antidepressants
speciﬁcally for facet joint-mediated pain have not been
performed. Although many various adjuvant pain medica-
tions have been used to treat radicular and chronic low
back pain, there have been no studies to date examining the
efﬁcacy of these drugs in patients with documented facet-
mediated low back pain.
Interventional treatment: radiofrequency denervation
When suspicion of facet joint-mediated pain is supported
by two successful diagnostic blocks, consideration of facet
joint denervation may be appropriate. First described by
Shealy in 1975 [124], radiofrequency denervation is a
procedure that involves lesioning the medial branches with
a combination of electric and magnetic ﬁelds. If these
nerves become insensate from the process, they cannot
relay pain from the facet joints. Radiofrequency ablation of
the medial branches is now a commonly used procedure to
provide more long-term relief of facet joint-mediated pain.
As with diagnostic medial branch blocks with local
anesthetic, the technique and protocol employed for
radiofrequency lesioning can have signiﬁcant impact on the
success of the procedure. An example of this was high-
lighted by Bogduk and colleagues in 1987 [125]. Prompted
by reports of poor clinical outcomes with radiofrequency
lesioning, they reported on the shape and size of lesions
made by the radiofrequency electrodes. It was discovered
that lesioning occurred around the distal shaft of the elec-
trode rather than directly at the tip. The consequence of this
ﬁnding is that suboptimal lesioning occurs if the electrode
is oriented directly on the nerve in a perpendicular position.
This prompted a revision in the accepted technique to
incorporate the placement of the electrode parallel to the
targeted medial branch.
Radiofrequency denervation has been shown in some
studies to provide signiﬁcant pain reduction in patients with
chronic low back pain for 6 [126] to 12 months [93, 106].
However, other studies have shown little beneﬁt to this
procedure. In either case, it is important to consider any
design ﬂaws and limitations of these studies. For example,
Gallagher et al. [126] examined 41 patients with chronic
low back pain who underwent either radiofrequency abla-
tionorashamtreatment.Theexactdeﬁnitionofasuccessful
single diagnostic intra-articular injection was not ade-
quately described. Nevertheless, there was a signiﬁcant
difference in outcomes observed between the radiofre-
quency group and sham group at 1 month. However, this
was seen only in the patients who had displayed a good
response to the diagnostic blocks. The precise procedure for
radiofrequency ablation was also not well described.
Van Kleef et al. [93] described 31 patients who had
responded positively (C50% improvement) to a single
diagnostic medial branch block and were randomly
assigned to either a radiofrequency group or a control
group. The control group underwent the identical proce-
dure as the radiofrequency group except for the use of
radiofrequency current. One-year follow-up showed sta-
tistically signiﬁcant difference between the treatment and
control groups, with higher number of successes (deﬁned
as at least 2 point reduction in VAS and 50% pain reduc-
tion) recorded in the treatment group. Unfortunately, there
were some important limitations. Only a single diagnostic
procedure leading to 50% or greater pain relief was
employed. There was also a small sample size perhaps
leading to sampling error.
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patients, all of whom had experienced what investigators
termed ‘‘signiﬁcant’’ improvement in low back pain for at
least 24 h after a single diagnostic facet joint injection of
both lidocaine 2% and triamcinolone. The patients were
randomized into control and treatment groups, who
received identical procedures with the exception that the
control group did not experience lesioning with heated
probes. There was no signiﬁcant difference in any of the
outcome measures at 12 weeks, which included functional
disability according to the Roland-Morris or Oswestry
scales, or pain according to the VAS scores. Although this
was one of the larger studies examining radiofrequency
denervation, it is also important to note that in this study,
only one diagnostic block was performed and there was no
set deﬁnition of what was accepted as a successful diag-
nostic block. Only ‘‘signiﬁcant pain relief’’ was described.
Furthermore, the description of the radiofrequency tech-
nique is incomplete and it is unclear whether the probe was
positioned parallel or perpendicular to the medial branch.
A more recent study by van Wijk [107] represents the
largest randomized double blind study examining the efﬁ-
cacy of radiofrequency ablation to date. Eighty-one
patients were randomized to radiofrequency ablation or a
sham procedure after facet joint pain was conﬁrmed with a
two level intra-articular facet joint block. There was no
difference in the combined primary outcome (VAS, anal-
gesic intake, and physical activity) measure at 3 months.
VAS scores improved in both the treatment and control
groups but there was no statistically signiﬁcant difference
between groups. In this study, the authors used a 50%
improvement in pain for determining a successful diag-
nostic facet joint block. However, although the authors
recognize that uncontrolled diagnostic blocks may have
false-positive effects with a low predictive value, con-
trolled diagnostic blocks were not performed.
Dreyfuss et al. [106] examined the efﬁcacy of lumbar
medial branch neurotomy with a thorough and compre-
hensive protocol, including stringent inclusion and
exclusion criteria. Facet joint pain was subsequently con-
ﬁrmed with both diagnostic and conﬁrmatory blocks of the
medial branches utilizing an 80% or greater pain relief
criteria for inclusion. Care was taken to ensure that the
radiofrequency electrode was positioned parallel to the
medial branch. Unique to this study is that 6 weeks after
neurotomy, patients underwent an electromyogram to
determine the presence or absence of denervation poten-
tials. Eighty-seven percent of patients obtained at least
60% relief of pain and 60% of patients obtained at least
90% relief of pain at 12 months. Although technically
sound, this study was limited by its lack of a control group.
Although the study examined cervical facet joint pain
rather than lumbarfacet joint pain, it isimportant to consider
the study by Lord et al. [108] who presented one of the most
rigorous protocols to date. This randomized, double-blind
controlled trial included patients who had cervical pain after
motor vehicle crashes that had undergone successful diag-
nostic controlled blocks. In order to proceed to radio-
frequency ablation, facet joint pain had to be conﬁrmed with
not two but three diagnostic blocks of the medial branches
employing 2% lidocaine, 0.5% bupivacaine, or saline under
strictdoubleblindconditions.Thestudypatientwasaccepted
for radiofrequency lesioning of the medial branches only if
they experienced 100% pain relief with the local anesthetic
blockandnoreliefwhennormalsalinehadbeeninjected.The
median time for return of at least 50% of preoperative pain
level was found to be 263 days in the active-treatment group
and 8 days in the control group (P = 0.04).
Conclusions
Despite some of the pitfalls associated with facet joint
blocks, they have been shown to be valid, safe, and reliable
as a diagnostic tool [128]. Medial branch denervation has
shown some promise for the sustained control of lumbar
facet joint-mediated pain, but at this time, there is insuf-
ﬁcient evidence that it is a wholly efﬁcacious treatment
option. This may be simply because we do not have enough
highly-powered randomized controlled studies to support
its use. Developing a universal algorithm for evaluating
facet joint-mediated pain and standard procedural tech-
niques may facilitate the performance of larger outcome
studies. Implementing guidelines for the comprehensive
reporting of both patient selection and the various aspects
of radiofrequency techniques as outlined by Geurts et al.
[129] will in turn, allow us to form more powerful evi-
dence-based conclusions.
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